References
- Disease burden and mortality estimates. World Health Organization. Available from: https://wwwwhoint/healthinfo/global_burden_disease/estimates/en/. 2000-2016.
- Heron M. Deaths: leading causes for 2017. Natl Vital Stat Rep. 2017;66(5):1–76.
- Adeloye D, Chua S, Lee C, Global Health Epidemiology Reference Group (GHERG), et al. Global and regional estimates of COPD prevalence: systematic review and meta-analysis. J Glob Health. 2015;5(2):020415 DecDOI:https://doi.org/10.7189/jogh.05-020415
- Rycroft CE, Heyes A, Lanza L, et al. Epidemiology of chronic obstructive pulmonary disease: a literature review. Int J Chron Obstruct Pulmon Dis. 2012;7:457–494. DOI:https://doi.org/10.2147/COPD.S32330
- Engelen MP, Schols AM, Lamers RJ, et al. Different patterns of chronic tissue wasting among patients with chronic obstructive pulmonary disease. Clin Nutr. 1999;18(5):275–280. DOI:https://doi.org/10.1016/S0261-5614(98)80024-1
- Engelen MP, Schols AM, Baken WC, et al. Nutritional depletion in relation to respiratory and peripheral skeletal muscle function in out-patients with COPD. Eur Respir J. 1994;7(10):1793–1797. DOI:https://doi.org/10.1183/09031936.94.07101793
- Schols AM, Broekhuizen R, Weling-Scheepers CA, et al. Body composition and mortality in chronic obstructive pulmonary disease. Am J Clin Nutr. 2005;82(1):53–59. DOI:https://doi.org/10.1093/ajcn.82.1.53
- Jones SE, Maddocks M, Kon SS, et al. Sarcopenia in COPD: prevalence, clinical correlates and response to pulmonary rehabilitation. Thorax. 2015;70(3):213–218. DOI:https://doi.org/10.1136/thoraxjnl-2014-206440
- Swallow EB, Reyes D, Hopkinson NS, et al. Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease. Thorax. 2007;62(2):115–120. DOI:https://doi.org/10.1136/thx.2006.062026
- Roig M, Eng JJ, MacIntyre DL, et al. Deficits in muscle strength, mass, quality, and mobility in people with chronic obstructive pulmonary disease. J Cardiopulm Rehabil Prev. 2011;31(2):120–124. DOI:https://doi.org/10.1097/HCR.0b013e3181f68ae4
- Attaway AH, Welch N, Hatipoglu U, et al. Muscle loss contributes to higher morbidity and mortality in COPD: an analysis of national trends. Respirology. 2021;26(1):62–71. DOI:https://doi.org/10.1111/resp.13877.
- Newman AB, Kupelian V, Visser M, Health ABC Study Investigators, et al. Sarcopenia: alternative definitions and associations with lower extremity function. J Am Geriatr Soc. 2003;51(11):1602–1609. DOI:https://doi.org/10.1046/j.1532-5415.2003.51534.x
- Schols AM, Soeters PB, Dingemans AM, et al. Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. Am Rev Respir Dis. 1993;147(5):1151–1156. DOI:https://doi.org/10.1164/ajrccm/147.5.1151
- Shen W, Punyanitya M, Wang Z, et al. Total body skeletal muscle and adipose tissue volumes: estimation from a single abdominal cross-sectional image. J Appl Physiol. 2004;97(6):2333–2338. DOI:https://doi.org/10.1152/japplphysiol.00744.2004
- Dasarathy S, Merli M. Sarcopenia from mechanism to diagnosis and treatment in liver disease. J Hepatol. 2016;65(6):1232–1244. DOI:https://doi.org/10.1016/j.jhep.2016.07.040
- Tanimura K, Sato S, Fuseya Y, et al. Quantitative assessment of erector spinae muscles in patients with chronic obstructive pulmonary disease. Annals ATS. 2016;13(3):334–341. DOI:https://doi.org/10.1513/AnnalsATS.201507-446OC
- McDonald ML, Diaz AA, Ross JC, et al. Quantitative computed tomography measures of pectoralis muscle area and disease severity in chronic obstructive pulmonary disease. A cross-sectional study. Annals ATS. 2014;11(3):326–334. DOI:https://doi.org/10.1513/AnnalsATS.201307-229OC
- Tsien C, Shah SN, McCullough AJ, et al. Reversal of sarcopenia predicts survival after a transjugular intrahepatic portosystemic stent. Eur J Gastroenterol Hepatol. 2013;25(1):85–93.
- Results of initial low-dose computed tomographic screening for lung cancer. New Eng J Med. 2013;368(21):1980–1991.
- Mazzone P, Powell CA, Arenberg D, et al. Components necessary for high-quality lung cancer screening: American College of Chest Physicians and American Thoracic Society Policy Statement. Chest. 2015;147(2):295–303. DOI:https://doi.org/10.1378/chest.14-2500
- Welch N, Dasarathy J, Runkana A, et al. Continued muscle loss increases mortality in cirrhosis: impact of aetiology of liver disease. Liver Int. 2020;40(5):1178–1188. DOI:https://doi.org/10.1111/liv.14358
- Ikezoe T, Mori N, Nakamura M, et al. Effects of age and inactivity due to prolonged bed rest on atrophy of trunk muscles. Eur J Appl Physiol. 2012;112(1):43–48. DOI:https://doi.org/10.1007/s00421-011-1952-x
- Ratnovsky A, Elad D, Halpern P. Mechanics of respiratory muscles. Respir Physiol Neurobiol. 2008;163(1–3):82–89. DOI:https://doi.org/10.1016/j.resp.2008.04.019
- Nakatani T, Nakashima T, Kita T, et al. Responses of exposure to cigarette smoke at three dosage levels on soleus muscle fibers in Wistar-Kyoto and spontaneously hypertensive rats. Jpn J Pharmacol. 2002;90(2):157–163. DOI:https://doi.org/10.1254/jjp.90.157
- Basic VT, Tadele E, Elmabsout AA, et al. Exposure to cigarette smoke induces overexpression of von Hippel-Lindau tumor suppressor in mouse skeletal muscle. Am J Physiol Lung Cell Mol Physiol. 2012;303(6):L519–27. DOI:https://doi.org/10.1152/ajplung.00007.2012
- Hansen MJ, Chan SP, Langenbach SY, et al. IL-17A and serum amyloid A are elevated in a cigarette smoke cessation model associated with the persistence of pigmented macrophages, neutrophils and activated NK cells. PLoS One. 2014;9(11):e113180 DOI:https://doi.org/10.1371/journal.pone.0113180
- Krüger K, Dischereit G, Seimetz M, et al. Time course of cigarette smoke-induced changes of systemic inflammation and muscle structure. Am J Physiol Lung Cell Mol Physiol. 2015;15309(2):L119–28. DOI:https://doi.org/10.1152/ajplung.00074.2015
- Gupta N, Pinto LM, Morogan A, et al. The COPD assessment test: a systematic review. Eur Respir J. 2014;44(4):873–884. DOI:https://doi.org/10.1183/09031936.00025214
- Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;4350(10):1005–1012. DOI:https://doi.org/10.1056/NEJMoa021322
- Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383. DOI:https://doi.org/10.1016/0021-9681(87)90171-8
- Stoller JK, Hupertz V, Aboussouan LS, et al. Alpha-1 antitrypsin deficiency. 2006 Oct 27 [Updated 2020 May 21]. In: Adam MP, Ardinger HH, Pagon RA, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2020. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1519/.
- Harris PA, Taylor R, Thielke R, et al. Research electronic data capture (REDCap)–a metadata-driven methodology and workflow process for providing translational research informatics support . J Biomed Inform. 2009;42(2):377–381. DOI:https://doi.org/10.1016/j.jbi.2008.08.010
- Southern BD, Scheraga RG, Yadav R. Managing interstitial lung disease detected on CT during lung cancer screening. Cleve Clin J Med. 2016;83(1):55–65. DOI:https://doi.org/10.3949/ccjm.83a.14157
- Dasarathy J, Periyalwar P, Allampati S, et al. Hypovitaminosis D is associated with increased whole body fat mass and greater severity of non-alcoholic fatty liver disease. Liver Int. 2014;34(6):e118–e127. DOI:https://doi.org/10.1111/liv.12312
- Fishman A, Martinez F, Naunheim K, et al. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med. 2003;348(21):2059–2073.
- Mortality Statistics. Ohio Dept of Health. 2020. (Date accessed December 7 2020.). Available from: https://odh.ohio.gov/wps/portal/gov/odh/home/data.
- Case AH, Hellkamp AS, Neely ML, et al. Associations between patient-reported outcomes and death or lung transplant in idiopathic pulmonary fibrosis. data from the idiopathic pulmonary fibrosis prospective outcomes registry. Ann Am Thorac Soc. 2020;17(6):699–705. DOI:https://doi.org/10.1513/AnnalsATS.201906-437OC
- Snyder L, Neely ML, Hellkamp AS, on behalf of the IPF-PRO™ Registry investigators, et al. Predictors of death or lung transplant after a diagnosis of idiopathic pulmonary fibrosis: insights from the IPF-PRO Registry. Respir Res. 2019;20(1):105. DOI:https://doi.org/10.1186/s12931-019-1043-9
- Durheim MT, Judy J, Bender S, et al. In-hospital mortality in patients with idiopathic pulmonary fibrosis: a US cohort study. Lung. 2019;197(6):699–707. DOI:https://doi.org/10.1007/s00408-019-00270-z
- Pulido T, Adzerikho I, Channick RN, et al. Macitentan and morbidity and mortality in pulmonary arterial hypertension. N Engl J Med. 2013;369(9):809–818. DOI:https://doi.org/10.1056/NEJMoa1213917
- Moore OA, Goh N, Corte T, et al. Extent of disease on high-resolution computed tomography lung is a predictor of decline and mortality in systemic sclerosis-related interstitial lung disease. Rheumatology (Oxford). 2013;52(1):155–160. DOI:https://doi.org/10.1093/rheumatology/kes289
- Alabed S, Shahin Y, Garg P, et al. Cardiac-MRI predicts clinical worsening and mortality in pulmonary arterial hypertension: a systematic review and meta-analysis. JACC Cardiovasc Imaging. 2020;S1936-878X(20)30731-2. DOI:https://doi.org/10.1016/j.jcmg.2020.08.013.
- Freemantle N, Calvert M, Wood J, et al. Composite outcomes in randomized trials: greater precision but with greater uncertainty? JAMA 2003;289(19):2554–2559. DOI:https://doi.org/10.1001/jama.289.19.2554
- Saure EW, Bakke PS, Lind Eagan TM, et al. Diffusion capacity and CT measures of emphysema and airway wall thickness – relation to arterial oxygen tension in COPD patients. Eur Clin Respir J. 2016;3(1):29141. DOI:https://doi.org/10.3402/ecrj.v3.29141
- Shin TR, Oh YM, Park JH, et al. The prognostic value of residual volume/total lung capacity in patients with chronic obstructive pulmonary disease. J Korean Med Sci. 2015;30(10):1459–1465. DOI:https://doi.org/10.3346/jkms.2015.30.10.1459
- Zafar MA, Tsuang W, Lach L, et al. Dynamic hyperinflation correlates with exertional oxygen desaturation in patients with chronic obstructive pulmonary disease. Lung. 2013;191(2):177–182. DOI:https://doi.org/10.1007/s00408-012-9443-3
- McCarthy B, Casey D, Devane D, et al. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2015;(2):CD003793. DOI:https://doi.org/10.1002/14651858.CD003793.pub3.
- Stoller JK, Gildea TR, Ries AL, et al. Lung volume reduction surgery in patients with emphysema and alpha-1 antitrypsin deficiency. Ann Thorac Surg. 2007;83(1):241–251. DOI:https://doi.org/10.1016/j.athoracsur.2006.07.080
- Celli BR, Locantore N, Tal-Singer R, et al. Emphysema and extrapulmonary tissue loss in COPD: a multi-organ loss of tissue phenotype. Eur Respir J. 2018;51(2):1702146. DOI:https://doi.org/10.1183/13993003.02146-2017
- Corlateanu A, Mendez Y, Wang Y, et al. Chronic obstructive pulmonary disease and phenotypes: a state-of-the-art. . Pulmonology. 2020;26(2):95–100. 2020/03/01/DOI:https://doi.org/10.1016/j.pulmoe.2019.10.006
- Joppa P, Tkacova R, Franssen FM, et al. Sarcopenic obesity, functional outcomes, and systemic inflammation in patients with chronic obstructive pulmonary disease. J Am Med Dir Assoc. 2016;17(8):712–718. DOI:https://doi.org/10.1016/j.jamda.2016.03.020
- de Blasio F, Di Gregorio A, de Blasio F, et al. Malnutrition and sarcopenia assessment in patients with chronic obstructive pulmonary disease according to international diagnostic criteria, and evaluation of raw BIA variables. Respir Med. 2018;134:1–5. DOI:https://doi.org/10.1016/j.rmed.2017.11.006
- Mazzarin C, Kovelis D, Biazim S, et al. Physical inactivity, functional status and exercise capacity in COPD patients receiving home-based oxygen therapy. COPD 2018;15(3):271–276. DOI:https://doi.org/10.1080/15412555.2018.1469608
- Paneroni M, Ambrosino N, Simonelli C, et al. Physical activity in patients with chronic obstructive pulmonary disease on long-term oxygen therapy: a cross-sectional study. Int J Chron Obstruct Pulmon Dis. 2019;14:2815–2823. DOI:https://doi.org/10.2147/COPD.S228465
- Ajime TT, Serré J, Wüst RCI, et al. Two weeks of smoking cessation reverse cigarette smoke-induced skeletal muscle atrophy and mitochondrial dysfunction in mice. Nicotine Tob Res. 2021;23(1):143–151. DOI:https://doi.org/10.1093/ntr/ntaa016
- Rom O, Reznick AZ, Keidar Z, et al. Smoking cessation-related weight gain-beneficial effects on muscle mass, strength and bone health. Addiction. 2015;110(2):326–335. DOI:https://doi.org/10.1111/add.12761
- Hersi M, Traversy G, Thombs BD, et al. Effectiveness of stop smoking interventions among adults: protocol for an overview of systematic reviews and an updated systematic review. Syst Rev. 2019;8(1):28. DOI:https://doi.org/10.1186/s13643-018-0928-x